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The cellular receptors for a coronavirus, mouse hepatitis virus (MHV), have been recently identified as one or more 
members of the carcinoembryonic antigen (CEA) family. The neurotropic JHM strain of MHV (MHV-JHM) possesses a 
highly fusogenic surface (S) glycoprotein. This protein is now shown to promote the spread of MHV into cells lacking 
the specific CEA-related MHV receptor. Resistant cells are recruited into MHV-induced syncytium with consequent 
production of progeny virus. Cell-to-cell spread of virus via membrane fusion without the requirement for specific cell 
surface receptor offers a novel way for virus to spread within infected hosts. o 1992 Academic PWS. IX. 
Attachment of virus to a host cell is the first step in 
any viral infection. This process has been shown for 
many viruses to be mediated by specific cell receptor 
molecules, although in some cases, receptors for a 
given virus vary on different cells (3, 4). The cellular 
receptors for several viruses, including poliovirus, rhi- 
novirus, echovirus 1, Epstein-Barr virus, human immu- 
nodeficiency virus (HIV), reovirus, rabies virus, and 
three coronaviruses, have been identified and partially 
characterized (1-7). In specific, one or more members 
of the carcinoembryonic antigen (CEA) family serve as 
cellular receptors for the A59 and JHM strains of 
mouse hepatitis virus (MHV) (MHV-A59 and MHV-JHM) 
and expression of CEA on the surface of some resis- 
tant cells renders them susceptible to MHV ((Z), T.G., 
S.P., unpublished observations). 
The viral protein involved in binding to the host cell 
has been identified for many viruses and in some cases 
this attachment protein or a second viral protein has 
been shown to mediate a subsequent plasma mem- 
brane fusion event (2, 8). This latter function leads to 
syncytium formation and rapid viral spread in tissue 
culture cells and, most likely, in animals as well. In the 
case of MHV, the spike (S) glycoprotein has dual func- 
tions. S both binds to cellular receptor and induces 
cell-to-cell fusion (9). Fusion may originate from either 
external virus (fusion from without) or infected cells (fu- 
sion from within) and is believed to require the pres- 
ence of receptor on uninfected cells. 
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MHV-JHM, like some other coronaviruses, encodes 
a highly fusogenic S glycoprotein. Fusion is evident 
following infection with MHV or with either recombi- 
nant vaccinia virus (VV) or recombinant baculovirus ex- 
pressing the coronavirus S protein (10, 11). Further- 
more, the recombinant constructs cause fusion of 
cells lacking the MHV cellular receptor. These experi- 
ments indicate that only the S protein is required for 
cell fusion. 
The ability of a virus to infect a cell not encoding its 
cellular receptor would greatly increase its potential 
host and tissue range. In this report, we show that 
MHV-JHM is capable of spreading to cells resistant to 
infection by virions. Spread only occurs when the re- 
sistant cells are exposed to cell-associated MHV and is 
a consequence of the strong receptor-independent fu- 
sion activity of the S protein. 
Unlike cells of murine origin, hamster and human 
fibroblasts are resistant to infection with MHV and in 
some cases, resistance occurs at the level of the virus 
receptor (2). To demonstrate that the JHM strain was 
similarly capable of infecting only murine cells, DBT 
(mouse astrocytoma) (72) BHK (baby hamster kidney), 
and RKl3 (rabbit kidney clone 13) cells were infected at 
a multiplicity of 0.2 plaque-forming units/cell (PFU/cell). 
Virus infection was measured qualitatively by an indi- 
rect immunofluorescence assay (IFA). At 22 hr postin- 
oculation (p.i.), only the DBT cell monolayers ex- 
pressed detectable levels of virus antigen (data not 
shown) confirming the species specificity of MHV- 
JHM. The JHM strain used in these experiments en- 
coded a full-length (4131 nucleotides) S protein (13). 
In sharp contrast, both BHK and RK13 cells were 
susceptible to infection with cell-associated MHV-JHM 
(Fig. 1). In these experiments, DBT cells in suspension 
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were infected with MHV-JHM (0.5 PFU/cell for 1 hr), 
washed extensively, and seeded onto empty plates or 
onto lawns of DBT, BHK, or RK13 cells. An immunofluo- 
rescence assay performed 22 hr later revealed that, in 
the absence of an underlying cell sheet, these infected 
cells remained mononuclear, unable to recruit the 
widely dispersed uninfected population into syncytia 
(Fig. 1G). Only 2-100/o of the suspended DBT cells 
were infected, rather than 40-50% expected at an 
m.o.i. of 0.5. This discrepancy may reflect either ineffi- 
cient adsorption in suspension (S. Stohlman, personal 
communication) or loss of receptor after trypsinization 
since the cells were removed from tissue culture plates 
immediately prior to infection. 
When similar numbers of infected DBT cells were 
seeded onto a lawn of uninfected DBT cells, large syn- 
cytia were apparent by 1 1 hr p.i. (Fig. 1 A), with involve- 
ment of the entire cell layer by 22 hr p.i. (data not 
shown). Comparing the number of syncytia at 11 hr 
with the number of infected cells observed in the sam- 
ple without an underlying lawn indicated that nearly 
every infected cell was able to form a syncytium. These 
results showed that virus transmission was efficient by 
this route and suggested that virus infected the under- 
lying monolayer via cell-to-cell spread and not via free 
virus. When BHK or RK13 cells were similarly overlaid 
with infected DBT cells, small syncytia were apparent 
by 11 hr p.i. (data not shown) and were more substan- 
tial by 22 hr p.i. (Figs. 1 C and 1 E). BHK cells were more 
susceptible to syncytium formation than were RK13 
cells as indicated both by the larger size of the individ- 
ual syncytium and by the higher ratio of syncytia to 
single cells. The average syncytium on BHK cells con- 
tained approximately 20-30 nuclei, whereas the RK13 
syncytia averaged two nuclei. The latter number re- 
flected the relatively high number of infected cells that 
remained unfused at 22 hr p.i. 
Previous results have shown that BHK cells trans- 
fected with the MHV cellular receptor will support vi- 
rion production, indicating that the cells were fully per- 
missive for all other functions required for viral replica- 
tion ((2) T.G., S.P., unpublished observations). To 
determine if BHK or RK13 cells recruited into syncytia 
would similarly support MHV-JHM production, a series 
of infected cultures were assayed for the presence of 
infectious progeny virus (Table 1). On average, BHK 
and RK13 cell monolayers overlaid with infected DBT 
cells produced 250 and 2 1 times more virus compared 
to that of the sample lacking a monolayer, in agree- 
ment with the IFA results. When DBT cells were titered 
in this assay, an increase of approximately 7800-fold 
was observed, consistent with involvement of the en- 
tire monolayer at 22 hr p.i. 
To demonstrate by another method that the underly- 
ing BHK cells were recruited into MHV-induced syncy- 
tia, BHK cells were transiently transfected with a plas- 
mid (pCMV$) encoding Escherichia co/i 8 galactosi- 
dase. One day later, MHV-infected DBT cells were 
seeded onto the transfected lawn and syncytia allowed 
to develop for 22 hr. Cells were then fixed and assayed 
both histochemically for p galactosidase and by IFA for 
viral antigen. As shown in Fig. 2, some syncytia were 
uniformly positive for p galactosidase activity (B) and 
viral antigen (A), confirming the recruitment of the BHK 
cells. 
Some strains of MHV encode a second surface gly- 
coprotein, HE, which could potentially serve as a viral 
attachment protein (14, 15). The MHV-JHM which we 
used synthesizes little or no HE protein (( 14) T.G., un- 
published observation), making it unlikely that this pro- 
tein was responsible for our results. However, two ap- 
proaches were taken to prove directly that receptor-in- 
dependent spread was S-mediated. First, syncytium 
formation was inhibited in DBT, BHK, and RK13 cells if 
either of two different anti-S monoclonal antibodies 
(5B19.2 and 5A13.5 (9)) was added to the cell superna- 
tant (data not shown). Second, others have shown that 
the S protein was capable of initiating syncytium for- 
mation in the absence of expression of other MHV pro- 
teins (10, 7 I). This was confirmed by dually infecting 
DBT cells with recombinant VV expressing T7 RNA 
polymerase (vTF7.3) (16) and a second VV encoding 
the MHV-JHM S glycoprotein (vTF7.3/S) (17, 78). 
These cells were extensively washed and seeded onto 
uninfected lawns of BHK and RK13 cells. As before, the 
number of infected cells observed in a sample without 
underlying cells was very similar to the number of syn- 
cytia noted on the BHK and RK13 lawns, suggesting 
spread from the DBT-infected cells. Syncytia were 
larger and formed earlier when the seeded cells were 
infected with vTF7.3/S than when these cells were in- 
fected with MHV. These results probably reflected a 
FIG. 1. Demonstration of spread of MHV infection to resistant BHK and RK13 cells. DBT cells were suspended to 1 O6 cells/ml by treatment with 
trypsin and EDTA and were mock-infected or infected with MHV-JHM (0.5 PFWcell) or MHWA59 (4 PFWcell). After 1 hr at 37°C cells were 
washed extensively to remove unbound vrrus. Aliquots (1 .O X 1 O5 cell) of the JHM-infected (A, C, E, G). mock-infected (B, D, F), and A59-infected 
(H) cells were then seeded onto 1 O-cm’ wells containing confluent lawns of either DBT (A, B), BHK (C, D, H), or RK13 (E, F) cells or onto empty 
wells(G). After 1 1 hr(A, B) or 22 hr(C-H), cells were rinsed with PBS, fixed with 10% formalin, permeabilized with 2% NP40, and incubated with a 
mixture of murine monoclonal antibodies specific for the nucleocapsid (N), matrix (M), and spike (S) MHV proteins. AntivIral antibody was 
detected with fluoroscein-conjugated goat anti-mouse antibody (Fab fragment). 
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TABLE 1 
MHV-JHM TITERS? IN BHK, RK13 AND DBT CELLS 
Exp. no. DBT BHK RK13 None 
1 NT 4.76 NT 2.59 
2 6.11 5.10 NT 2.62 
3 6.23 4.41 4.18 1.85 
4 NT 4.25 3.54 2.60 
5 6.74 5.82 3.66 2.69 
Mean 6.36 4.87 3.79 2.47 
Note. Plates (10 cm’) containing no ceils (“none”) as well as those 
containing confluent DBT, BHK, and RK13 cells monolayers were 
overlaid with MHV-JHM-infected DBT cells as described in Fig. 1. 
After 22 hr, cells were disrupted by repeated cycles of freezing and 
thawing. Cellular debris was removed by centrifugation and virus 
titered on DBT indicator cells. In each experiment, two to six individ- 
ual wells were harvested and each sample was titered in duplicate. 
NT, not tested. 
a Geometric mean titers per milliliter are shown. 
higher surface density of the S protein, since the S 
protein is greatly overproduced in this VV system (18, 
19) (Figure 3). 
To determine whether there was a correlation be- 
tween the neurovirulence of MHV-JHM and its fuso- 
genie properties, the ability of MHV-JHM to cause fu- 
sion was compared to that of the minimally pathogenic 
MHV-A59 (20). The S proteins of these two viruses 
share greater than 90% homology at the nucleic acid 
and protein level, with the major difference being a 
156-nucleotide deletion in the MHV-A59 sequence 
(13, 21). To determine whether these differences af- 
fected the ability of the virus to cause syncytium forma- 
tion, MHV-A59-infected DBT cells were seeded onto a 
lawn of BHK cells. As shown in Fig. 1 H, few of these 
cells were incorporated into syncytia and these syncy- 
tia were in general much smaller than what was ob- 
served after infection with the pathogenic MHV-JHM 
strain. 
Together these results indicate that the extent of re- 
ceptor-independent virus spread is determined by both 
virus strain and host cell type. Thus, neurovirulent 
MHV-JHM disseminates more extensively in this assay 
than the less virulent A59 strain. This variability in syn- 
cytium formation most likely reflects structural differ- 
ences between the two S proteins, but other factors, 
such as transport to the cell surface or efficiency of 
cleavage of S (22) could also affect this process. The 
increased fusion activity may be an important factor in 
the greater virulence of MHV-JHM in animals, although 
the two viruses are sufficiently different so that other 
viral genes could also have a role in this process. 
Infection spreads more rapidly in BHK cells relative 
to RK13 cells. This may reflect differences in the com- 
position of the host cell plasma membrane. Indeed, 
MHV-induced fusion is known to be affected by lipid 
content (23, 24). Another cell line, OBL-21A, a retrovi- 
rus-transformed cell of neural derivation, is susceptible 
to infection with MHV-JHM but essentially refractory to 
MHV-induced fusion (17). 
Cell type may be important in another way as well, 
since MHV binds to some cells, but is unable to initiate 
infection efficiently (25, 26). Virus replication proceeds 
normally in the small number of productively infected 
cells, suggesting that the block to infection with MHV 
occurs at an early stage of viral replication such as 
internalization. Whethercell-associatedviruswouldab- 
rogate such a block is not known at present but is 
FIG. 2. Recruitment of BHK cells into MHV-induced syncytia. BHK 
cells (50-60% confluent) in lo-cm2 wells were transfected with 
CMV-8 @ galactosidase under the control of the human CMV major 
immediate-early promoter and enhancer (Clontech Laboratories, 
Inc.)) using lipofectin (Bethesda Research Laboratories) according to 
the manufacturer’s specifications. After 24 hr, these cells were over- 
laid with MHV-JHM-infected DBT cells as described in Fig. 1. After 
an additional 22 hr, cells were fixed as above with 10% formalin, 
washed, and treated with 5-bromo-4-chloro-3-indolyl-P-o-galacto- 
side (X-gal) (33). After 6-8 hr, cells were assayed for viral antigen as 
described in Fig. 1. Cells dually stained for B galactosidase and viral 
antigen were detected by sequential light and fluorescent micros- 
copy. 
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FIG. 3. Demonstration of syncytium-forming capacity of MHV-JHM S glycoprotein. The full-length S sequence (4131 nucleotides) (17) was 
subcloned into the VV shuttle vector pTM 1 (34) and then recombined into VV as previously described (18). DBT cells were trypsinized and dually 
infected in suspension with this virus and a VV recombinant expressing T7 RNA polymerase (vTF7.3) (76). Infection multiplicity for each virus was 
4 PFU/cell. Dually infected (A, C) and mock-treated (B, D) cells were seeded onto coverslips containing confluent lawns of either BHK (A, B) or 
RKl3 (C, D) cells. Cells were fixed at 1 1 hr p.i. and processed as in Fig. 1. 
important to determine since the result would affect 
the ultimate host range of the virus. 
These results show that virus can spread to cultured 
cells lacking specific viral receptors and suggest that 
virus may also spread within infected animals by a re- 
ceptor-independent mechanism. One case where this 
might be prominent is in MHV infections of relatively 
resistant hosts such as rats and monkeys. Both can be 
infected with MHV if large amounts are used and if 
virus is administered in the form of cellular lysate or 
brain tissue homogenate (27-29). 
Receptor-independent spread would require the 
presence of a surface protein with fusion activity, such 
as is present in paramyxoviridae, some herpesviridae, 
and in lentivirinae. Recently, it has been shown that 
cells expressing no HIV proteins but the fusogenic 
gp41 transmembrane protein could initiate syncytium 
formation in cells normally resistant to HIV, consistent 
with this model (30). Although this mechanism does 
not depend on the presence of a high-affinity cellular 
receptor, it may still require cell-cell contact via adhe- 
sion molecules or binding to a specific, ubiquitous cell 
surface protein or sugar epitope. 
This mechanism may have a role in human and ani- 
mal diseases, such as subacute sclerosing panen- 
cephalitis (SSPE), in which virus spreads by cell-to-cell 
contact in the presence of a strong host immunological 
response. Many SSPE variants have alterations or de- 
letions in the cytoplasmic domain of the fusion (F) pro- 
tein (3 I). This part of the F protein is believed to interact 
with the matrix (M) protein and its loss may facilitate 
lateral movement of the protein, with increased fuso- 
genicity. Similarly, some variants of HIV-2 with in- 
creased ability to fuse uninfected tissue culture cells 
have env proteins deleted in their cytoplasmic domains 
(32). The role of these changes which increase fuso- 
genicity in facilitating receptor-independent spread is 
not known at present, although by analogy with our 
522 SHORT COMMUNICATIONS 
results, such changes would make it more likely that 
this mechanism would occur. 
The assay described in this report will be useful in 
studies of viral entry, since it will now be possible to 
separate the receptor binding event from fusion. Vari- 
ant S proteins expressed in native MHV or in VV recom- 
binants are both amenable to study by this technique 
and it should be possible to determine the effects on 
fusogenicity of individual mutations in the S protein. 
In summary, MHV-JHM has the potential to infect 
nominally resistant cells by a receptor-independent 
mechanism. The role of such spread in infected ani- 
mals is not proven at present, but receptor-indepen- 
dent spread potentially provides an additional way for 
virus to increase its host and tissue range. In addition, 
the possible contribution of receptor-independent 
spread must be considered in studies of the trafficking 
of MHV in infected animals. 
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